Granahan Investment Management’s Dare Bioscience DARE Stock Holding History

Granahan Investment Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,010	Closed	-$755K	–	233
2016 Q3	$755K	Buy	6,010 +108	+2%	+$24.2K	0.02%	199
2016 Q2	$1.5M	Sell	5,902 -181	-3%	-$57.9K	0.05%	196
2016 Q1	$1.98M	Sell	6,083 -287	-5%	-$80.9K	0.07%	195
2015 Q4	$2.14M	Buy	6,370 +3,226	+103%	+$1.34M	0.07%	212
2015 Q3	$1.38M	Buy	3,144 +375	+14%	+$189K	0.04%	234
2015 Q2	$1.53M	Buy	2,769 +1,171	+73%	+$804K	0.04%	227
2015 Q1	$1.73M	Buy	+1,598	New	+$1.55M	0.05%	216

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Granahan Investment Management's DARE Position: Q4 2016 in Review

Granahan Investment Management sold out of Dare Bioscience (DARE) in Q4 2016, closing a stake of 6,010 shares — an estimated $755K sold.

Granahan Investment Management first reported a position in DARE in Q1 2015 and held it in 7 quarters. The position peaked at $2.14M in Q4 2015. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2016.

Granahan Investment Management reported no remaining Dare Bioscience position as of Q4 2016 after selling out during the quarter.
Granahan Investment Management sold 6,010 Dare Bioscience shares in Q4 2016, an estimated $755K.
Granahan Investment Management first reported a position in Dare Bioscience in Q1 2015 and held it in 7 quarters.
Granahan Investment Management's Dare Bioscience position peaked at $2.14M in Q4 2015.
30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2016.

Based on Granahan Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.